Department of Pharmacy and Pharmacology, University of Bath, Bath BA2 7AY, U.K.
Roche Pharma Research and Early Development, Roche Innovation Center Basel, Therapeutic Modalities, Small Molecule Research, Isotope Synthesis, F. Hoffmann-La Roche Ltd, CH-4070 Basel, Switzerland.
Bioconjug Chem. 2021 May 19;32(5):1027-1033. doi: 10.1021/acs.bioconjchem.1c00202. Epub 2021 Apr 28.
An efficient procedure to access tritium-labeled maleimide derivatives in a high specific activity has been developed. -Substituted maleimides containing the hydroxy functionality are -methylated in a three-step synthesis route, including (1) Diels-Alder protection of the maleimide core, (2) -methylation by the use of commercially available [H]methyl nosylate, and (3) deprotection by retro-Diels-Alder reaction. With our procedure, -hydroxyalkyl maleimide derivatives can be labeled in overall radiochemical yields of 13-15% and in >98% radiochemical purity. The major advantage of -alkoxy maleimides in comparison to -alkylated maleimides such as -ethylmaleimide is their lower volatility, which enables safer handling with respect to radiation-safety protection. Tritium-labeled maleimide building blocks allow subsequent Michael-type conjugation reactions of thiol-containing biomolecules for mechanistic or studies.
已经开发出一种高效的方法,可将高比活度的氚标记马来酰亚胺衍生物转化为简体中文。 -取代的马来酰亚胺含有羟基官能团,通过包括(1)马来酰亚胺核的 Diels-Alder 保护,(2)使用市售的 [H]甲基对甲苯磺酸酯进行 -甲基化,和(3)通过逆 Diels-Alder 反应进行脱保护的三步合成路线进行 -甲基化。通过我们的方法,可以以 13-15%的总放射性化学产率和 >98%的放射性化学纯度标记 -羟烷基马来酰亚胺衍生物。与 -乙基马来酰亚胺等 -烷基化马来酰亚胺相比,-烷氧基马来酰亚胺的主要优势在于其挥发性较低,这使得在辐射安全保护方面能够更安全地处理。氚标记的马来酰亚胺砌块允许随后进行含巯基生物分子的迈克尔型共轭反应,用于机制或研究。